Aceto reported -10854000 in Net Income for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acasti Pharma ACST:US C$ -5.65M 0.5M
Aceto ACET:US -10854000 10.46M
Agile Therapeutics AGRX:US $ -17.64M 0.51M
Glaxosmithkline GSK:US $ 1395M 322M
Idera Pharmaceuticals IDRA:US $ -7.56M 123.3M
Merk MRK:US $ 1545M 1634M
Novartis NVS:US $ 2896M 837M
Pain Therapeutics PTIE:US $ -5.12M 1.6M
Pfizer PFE:US $ 5564M 686M
Prestige Brands PBH:US $ 57.76M 22.24M
Quaker Chemical KWR:US $ 33.57M 5.04M